These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Cytokine-induced killer cell fusion to lower recurrence of hepatocellular carcinoma after transcatheter arterial chemoembolization sequentially combined with radiofrequency ablation: a randomized trial]. Zhao M; Wu PH; Zeng YX; Xia JC; Zhang FJ; Xian LJ; Zhang YP; Zhou K; Fan WJ; Zhang L; Gao F; Zhou QM Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(26):1823-8. PubMed ID: 17054858 [TBL] [Abstract][Full Text] [Related]
44. [Long-term result of combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of hepatocellular carcinoma]. Chen XM; Luo PF; Lin HH; Zhou ZJ; Shao PJ; Fu L; Li WK Ai Zheng; 2004 Jul; 23(7):829-32. PubMed ID: 15248922 [TBL] [Abstract][Full Text] [Related]
45. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy]. Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291 [TBL] [Abstract][Full Text] [Related]
46. A comparative study of damage to liver function after TACE with use of low-dose versus conventional-dose of anticancer drugs in hepatocellular carcinoma. Lu W; Li YH; Yu ZJ; He XF; Chen Y; Zhao JB; Zhu ZY Hepatogastroenterology; 2007; 54(77):1499-502. PubMed ID: 17708284 [TBL] [Abstract][Full Text] [Related]
47. Transarterial chemoembolization for primary hepatocellular carcinoma in patients at high risk. Kothary N; Weintraub JL; Susman J; Rundback JH J Vasc Interv Radiol; 2007 Dec; 18(12):1517-26; quiz 1527. PubMed ID: 18057286 [TBL] [Abstract][Full Text] [Related]
48. Two doses of oral sustained-release tramadol do not reduce pain or morphine consumption after modified radical mastectomy: a randomized, double blind, placebo-controlled trial. Thienthong S; Krisanaprakornkit W; Taesiri W; Thaninsurat N; Utsahapanich S; Klaichanad C J Med Assoc Thai; 2004 Jan; 87(1):24-32. PubMed ID: 14971531 [TBL] [Abstract][Full Text] [Related]
49. Prediction of viable tumor in hepatocellular carcinoma treated with transcatheter arterial chemoembolization: usefulness of attenuation value measurement at quadruple-phase helical computed tomography. Kim SH; Lee WJ; Lim HK; Lim JH J Comput Assist Tomogr; 2007; 31(2):198-203. PubMed ID: 17414753 [TBL] [Abstract][Full Text] [Related]
50. [Efficacy and toxicity of transcatheter arterial chemoembolization with Cisplatin suspended in lipiodol for unresectable hepatocellular carcinoma]. Uyama N; Hatano E; Maetani Y; Isoda H; Shibata T; Taura K; Oe S; Naito M; Yasuchika K; Fujii H; Ikai I; Uemoto S Gan To Kagaku Ryoho; 2008 May; 35(5):775-80. PubMed ID: 18487912 [TBL] [Abstract][Full Text] [Related]
51. Pulmonary embolism after transcatheter arterial chemoembolization. Shiah HS; Liu TW; Chen LT; Chang JY; Liu JM; Chuang TR; Lee WS; Whang-Peng J Eur J Cancer Care (Engl); 2005 Dec; 14(5):440-2. PubMed ID: 16274465 [TBL] [Abstract][Full Text] [Related]
52. [Chemoembolization of hepatocellular carcinoma in cases of isolated liver involvement]. Galanski M; Schmoll E; Reichelt S; Böhmer G; Prokop M; Schaefer C; Schüler A; Ringe B; Schmidt FW; Schmoll HJ Radiologe; 1992 Feb; 32(2):49-55. PubMed ID: 1314400 [TBL] [Abstract][Full Text] [Related]
53. Chemoembolization for small hepatocellular carcinoma. Nakamura H; Oi H Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():144-7. PubMed ID: 9210897 [No Abstract] [Full Text] [Related]
54. [The effect of lidocaine HCL aerosol on postoperative pain in tonsillectomy patients]. Susaman N; Kaygusuz I Kulak Burun Bogaz Ihtis Derg; 2002; 9(1):37-40. PubMed ID: 12122623 [TBL] [Abstract][Full Text] [Related]
55. Post embolization syndrome in doxorubicin eluting chemoembolization with DC bead. Pomoni M; Malagari K; Moschouris H; Spyridopoulos TN; Dourakis S; Kornezos J; Kelekis A; Thanos L; Chatziioanou A; Hatjimarkou I; Marinis A; Koskinas J; Kelekis D Hepatogastroenterology; 2012 May; 59(115):820-5. PubMed ID: 22024228 [TBL] [Abstract][Full Text] [Related]
56. [Hyperthermal lipiodol embolization and thermocoagulation for the treatment of primary hepatocellular carcinoma]. Li C; Xu D; Xu D; Li X; Zhang W; Liu Y Zhonghua Gan Zang Bing Za Zhi; 2002 Jun; 10(3):174-6. PubMed ID: 12113669 [TBL] [Abstract][Full Text] [Related]
57. Hepatic release of erythropoietin induced by transarterial chemoembolization in patients with hepatocellular carcinoma. Pirisi M; Fabris C; Soardo G; Falleti E; Gasparini D; Vitulli D; Toniutto P; Gonano F; Bartoli E Hepatology; 1995 Jul; 22(1):148-52. PubMed ID: 7601407 [TBL] [Abstract][Full Text] [Related]
58. Longitudinal quality of life assessment of patients with hepatocellular carcinoma after primary transarterial chemoembolization. Wible BC; Rilling WS; Drescher P; Hieb RA; Saeian K; Frangakis C; Chen Y; Eastwood D; Kim HS J Vasc Interv Radiol; 2010 Jul; 21(7):1024-30. PubMed ID: 20621715 [TBL] [Abstract][Full Text] [Related]